Effectors regulatory T cells in pregnancy (and autoimmunity?)

References

• Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol.7, 320–338 (1953).
   Google Scholar
• Gershon RK, Kondo K. Infectious immunological tolerance. Immunology21(6), 903–914 (1971).
   PubMed Web of Science ®Google Scholar
• Baker PJ, Amsbaugh DF, Stashak PW, Caldes G, Prescott B. Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide. J. Immunol.128(3), 1059–1062 (1982).
   PubMed Web of Science ®Google Scholar
• Gershon RK, Cohen P, Hencin R, Liebhaber SA. Suppressor T cells. J. Immunol.108(3), 586–590 (1972).
   PubMed Web of Science ®Google Scholar
• Trowsdale J, Betz AG. Mother’s little helpers: mechanisms of materno foetal tolerance. Nat. Immunol.7(3), 241–245 (2006).
   Google Scholar
• Funakoshi N, Ohno T, Kanoh T et al. Aγglobulinemia in a pregnant woman. Tohoku J. Exp. Med.149(4), 359–365 (1986).
   PubMed Web of Science ®Google Scholar
• Mattson R, Sulila P, Bernadotte F, Mattsson A. Allopregnancy in B-cell deprived C57/BL mice – an investigation focusing on the relationship between survival of the fetuses and anti-paternal immune activity of the mothers. Dev. Comp. Immunol.12/1, 167–176 (1988).
   Google Scholar
• Smith RN, Powell AE. The adoptive transfer of pregnancy-induced unresponsiveness to male skin grafts with thymus-dependent cells. J. Exp. Med.146, 899–904 (1977).
   PubMedGoogle Scholar
• Simpson E, Chandler P, Pole D. A model of T-cell unresponsiveness using the male-specific antigen, H-Y. Cell. Immunol.2, 251–257 (1981).
   Google Scholar
• Chaouat G, Voisin GA, Escalier D, Robert P. Facilitation reaction (enhancing antibobies and suppressor cells) and rejection reaction (sensitized cells) from the mother to the paternal antigens of the conceptus. Clin. Exp. Immunol.35, 13–24 (1979).
   PubMed Web of Science ®Google Scholar
• Chaouat G, and Voisin GA. Regulatory T cell subpopulations in pregnancy. I. Evidence for suppressive activity of the early phase of MLR. J. Immunol.122, 1383–1388 (1979).
   PubMedGoogle Scholar
• Chaouat G, Voisin GA. Regulatory T cells in pregnancy. III. Comparison of early acting and late acting suppressor T cells in MLR: evidence for involvement of differential T-cell subsets. Immunology44(2), 393–400 (1981).
   PubMedGoogle Scholar
• Chaouat G, Voisin GA. Regulatory T cells in pregnancy. IV. Genetic characteristics and mode of action of early MLR suppressive T cell subpopulations. J. Immunol.127(4), 1335–1339 (1981).
   PubMedGoogle Scholar
• Chaouat G, Voisin GA. Regulatory T cells in pregnancy. V. Allopregnancy-induced T-cell-suppressor factor is H-2 restricted and bears Ia determinants. Cell. Immunol.62(1), 186–195 (1981).
   PubMedGoogle Scholar
• Chaouat G, Monnot P, Hoffmann M, Voisin GA. Regulatory T cells in pregnancy. VI. Evidence for T-cell-mediated suppression of CTL generation toward paternal alloantigens. Cell. Immunol.68(2), 322–331 (1982).
   PubMedGoogle Scholar
• Chaouat G, Chaffaux S, Voisin GA. Immuno-active products of placenta (I). J. Reprod. Immunol.2, 127–136 (1980).
   Google Scholar
• Kovithavongs T, Dossetor JB.Suppressor cells in human pregnancy. Transplant Proc.10(4), 911–913 (1978).
   PubMedGoogle Scholar
• Engleman EG, McMichael AJ, Batey ME, McDevitt HO. A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression. J. Exp. Med.147(1), 137–146 (1978).
   PubMedGoogle Scholar
• Engleman EG, McMichael AJ, McDevitt HO. Suppression of the mixed lymphocyte reaction in man by a soluble T-cell factor. Specificity of the factor for both responder and stimulator J. Exp. Med.147(4), 1037–1046 (1978).
   PubMedGoogle Scholar
• Clark DA, McDermott MR, Szewczuk MR. Impairment of host-versus-graft reaction in pregnant mice. II. Selective suppression of cytotoxic T-cell generation correlates with soluble suppressor activity and with successful allogeneic pregnancy. Cell. Immunol.52(1), 106–118 (1980).
   PubMed Web of Science ®Google Scholar
• Clark DA, Chaput A, Tutton B. Active suppression of host versus graft reaction in pregnant mice. VII. Spontaneous abortion of CBA × DBA/2 foetuses in the uterus of CBA/J mice correlates with deficient non-T suppressor cell activity. J. Immunol.136, 1668–1771 (1986).
   PubMed Web of Science ®Google Scholar
• Clark DA, Slapsys R, Chaput A et al. Immunoregulatory molecules of trophoblast and decidual suppressor cell origin at the maternofetal interface. Am. J. Reprod. Immunol. Microbiol.10(3), 100–104 (1986).
   PubMed Web of Science ®Google Scholar
• Clark DA, Flanders KC, Hirte H et al. Characterization of murine pregnancy decidua transforming growth factor β. I. Transforming growth factor β 2-like molecules of unusual molecular size released in bioactive form. Biol. Reprod.52(6), 1380–1388 (1995).
   PubMedGoogle Scholar
• Steinmetz M, Minard K, Horvath S et al. A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature300(5887), 35–42 (1982).
   PubMedGoogle Scholar
• Hood L, Steinmetz M, Malissen B. Genes of the major histocompatibility complex of the mouse. Annu. Rev. Immunol.1, 529–568 (1983).
   PubMed Web of Science ®Google Scholar
• Chaouat G, Mathieson BJ, Asofsky R. Regulatory mechanisms in the mixed lymphocyte reaction: evidence for the requirement of two T cells to interact in the generation of effective suppression. J. Immunol.129(2), 502–508 (1982).
   PubMedGoogle Scholar
• Munro A.The I-J paradox remains unsolved. Nature.306(5943), 537–538 (1983).
   PubMedGoogle Scholar
• Marx JL. Tracking the lost I-J suppressor region. Science223(4636), 573–574 (1984).
   PubMedGoogle Scholar
• Chaouat G, Liacopoulos J, Briffaux M, Liacopoulos P. Non specific suppressive activity from tumor cell lines used for hybridisation, and selection of subclones devoid of such activity. Immunology54, 363–368 (1985).
   PubMedGoogle Scholar
• Green DR, Webb DR. Saying the ‘S’ word in public. Immunol. Today14(11), 523–525 (1993).
   PubMedGoogle Scholar
• Chaouat G, Kiger N, Wegmann TG. Vaccination against spontaneous abortion in mice. J. Reprod. Immunol.8, 389–394 (1983).
   Google Scholar
• Chaouat G, Kolb JP, Kiger N, Stanislawski M, Wegmann TG. Immunological concomitants of vaccination against abortion in mice. J. Immunol.134, 1594–1598 (1985).
   PubMedGoogle Scholar
• Chaouat G, Kiger N, Chaouat G, Kolb JP, Wegmann TG, Guenet JL. Immunogenetic studies of spontaneous abortion in mice. I. Preimmunisation of the mother with allogeneic spleen cells. J. Immunol.134, 2966–2972 (1985).
   PubMedGoogle Scholar
• Chaouat G, Clark DA, Wegmann TG. Genetics aspects of the CBA/J × DBA/2 J and B10 × B10.A models of murine spontaneous abortions and prevention by leukocyte immunisation. 18th RCOG Study Group. In: Early Pregnancy Loss. Mechanisms and Treatment. RCOG. Allen WR, Clark DA, Gill TJ 3rd, Mowbray JF, Robertson WR (Eds). RCOG Press, London, UK 89–105 (1988).
   Google Scholar
• Kiger N, Chaouat G, Kolb JP, Wegmann TG, Guenet JL. Immunogenetic studies of spontaneous abortion in mice. Preimmunization of females with allogeneic cells. J. Immunol.134(5), 2966–2970 (1985).
   PubMedGoogle Scholar
• Bobe P, Chaouat G, Stanislawski M, Kiger N. Immunogenetics of spontaneous abortion in mice. II. Antiabortive effects are independent of systemic regulatory mechanisms. Cell. Immunol.98, 577–586 (1986).
   Google Scholar
• Bobe P, Kiger N. Immunogenetic studies of spontaneous abortion in mice. III. Non-H-2 antigens and gestation. J. Immunogenet.16(3), 223–231 (1989).
   PubMedGoogle Scholar
• Clark DA, Chaouat G, Guenet JL, Kiger N. Local active suppression and successful vaccination against spontaneous abortion in CBA/J mice. J. Reprod. Immunol.10(1), 79–85 (1987).
   PubMedGoogle Scholar
• Wegmann TG. Fetal protection against abortion: is it immuno suppression or immuno stimulation ? Ann. Immunol. Inst. Pasteur.135D, 309–311 (1984).
   Google Scholar
• Chaouat G, Menu E, Athanassakis I, Wegmann TG. Maternal T cells regulate placental size and fetal survival. Reg. Immunol.1(3), 143–148 (1988).
   PubMedGoogle Scholar
• Robertson SA, Mau VJ, Hudson SN, Tremellen KP. Cytokine leukocyte networks and the establishment of pregnancy. Am. J. Reprod. Immunol.37, 438–443 (1997).
   PubMedGoogle Scholar
• Robertson SA, O’Connell AC, Hudson SN, Seamark RF. Granulocyte–macrophage colony-stimulating factor (GM-CSF) targets myeloid leukocytes in the uterus during the post-mating inflammatory response in mice. J. Reprod. Immunol.46(2), 131–154 (2000).
   PubMedGoogle Scholar
• O’Leary S, Jasper MJ, Warnes GM, Armstrong DT, Robertson SA. Seminal plasma regulates endometrial cytokine expression, leukocyte recruitment and embryo development in the pig. Reproduction128(2), 237–247 (2004).
   PubMed Web of Science ®Google Scholar
• Robertson SA. Seminal fluid signaling in the female reproductive tract: lessons from rodents and pigs. J. Anim. Sci.85(Suppl. 13), E36–E44 (2007).
   Google Scholar
• Wegmann TG, Lin H, Guilbert L, Mossman TH. Bidirectional cytokines interactions in the materno fetal relationship: successful allopregnancy is a Th2 phenomenon. Immunol. Today14, 353–355 (1993).
   PubMedGoogle Scholar
• Lin H, Mossmann TR, Guibert L, Tuntipopat S, Wegmann TG. Synthesis of T helper-2 cytokines at the maternal fetal interface. J. Immunol.151, 4562–4573 (1993).
   PubMed Web of Science ®Google Scholar
• Chaouat G, Assal Meliani A, Martal J et al. IL-10 prevents inflammatory cytokine-mediated foetal death and is inducible by tau interferon. J. Immunol.152, 2411–2420 (1995).
   Google Scholar
• Bell SC, Billington WD. Anti-fetal allo-antibody in the pregnant female. Immunol. Rev.75, 5–30 (1983).
   PubMedGoogle Scholar
• Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med.161(1), 72–87 (1985).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol.155(3), 1151–1164 (1995).
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science299(5609), 1057–1061 (2003).
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol.4(4), 330–336 (2003).
   PubMed Web of Science ®Google Scholar
• Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol.5, 266–271 (2004).
   PubMed Web of Science ®Google Scholar
• Athanassakis I, Chaouat G, Wegmann TG. The effects of anti-CD4 and anti-CD8 antibody treatment on placental growth and function in allogeneic and syngeneic murine pregnancy. Cell. Immunol.129(1), 13–21 (1990).
   PubMedGoogle Scholar
• Darrasse-Jeze G, Klatzmann D, Charlotte F, Salomon BL, Cohen JL. CD4+CD25+ regulatory/suppressor T cells prevent allogeneic fetus rejection in mice. Immunol. Lett.102(1), 106–109 (2006).
   PubMed Web of Science ®Google Scholar
• Sulila P, Holmdahl R, Hansson I, Bernadotte F, Mattsson A, Mattsson R. An investigation of allogeneic pregnancy in multiparous mice subjected to in vivo depletion of CD8 (Ly2)-positive lymphocytes by monoclonal antibody treatment. J. Reprod. Immunol.14/3, 235–245 (1988).
   Google Scholar
• Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science270(5236), 630–633 (1995).
   PubMed Web of Science ®Google Scholar
• Jiang SP, Vacchio MS. Multiple mechanisms of peripheral T cell tolerance to the foetal ‘allograft’. J. Immunol.160, 3086–3090 (1998).
   PubMed Web of Science ®Google Scholar
• Vacchio MS, Hodes RJ. Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy. J. Immunol.174(8), 4657–4661 (2005).
   PubMedGoogle Scholar
• Hunt JS, Vasmer D, Ferguson TA, Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol.158, 4122–4128 (1997).
   PubMed Web of Science ®Google Scholar
• Runic R, Lockwood CJ, Ma Y, Dipasquale B, Guller S. Expression of Fas ligand by human cytotrophoblasts: implication in placentation and fetal survival. J. Clin. Endocrinol. Metab.81, 3119–3122 (1996).
   PubMedGoogle Scholar
• Uckan D, Steele A, Chery BY et al. Trophoblasts express Fas ligand. A proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod.3, 655–662 (1997).
   PubMed Web of Science ®Google Scholar
• Chaouat G, Clark DA. FAS/FAS ligand interaction at the placental interface is not required for the success of allogeneic pregnancy in anti-paternal MHC preimmunized mice. Am. J. Reprod. Immunol.2, 108–115 (2001).
   Google Scholar
• Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science281(5380), 1191–1193 (1998).
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J. Reprod. Immunol.52(1–2), 5–13 (2001).
   PubMed Web of Science ®Google Scholar
• Clark DA, Blois S, Kandil J, Handjiski B, Manuel J, Arck PC. Reduced uterine indoleamine 2,3-dioxygenase versus increased TH1/TH2 cytokine ratios as a basis for occult and clinical pregnancy failure in mice and humans. Am. J. Reprod. Immunol.54(4), 203 (2005).
   PubMedGoogle Scholar
• Saito S, Sasaki Y, Sakai M. CD4+CD25high regulatory T cells in human pregnancy. J. Reprod. Immunol.65(2), 111–120 (2005).
   PubMed Web of Science ®Google Scholar
• Shigeru S, Akitoshi N, Subaru MH, Shiozaki A. The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J. Reprod. Immunol. (Epub ahead of print) (2007).
   PubMedGoogle Scholar
• Saito S, Shiozaki A, Sasaki Y, Nakashima A, Shima T, Ito M. Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto–maternal tolerance. Semin. Immunopathol.29(2), 115–122 (2007).
   PubMed Web of Science ®Google Scholar
• Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol. Hum. Reprod.12(5), 301–308 (2006).
   PubMed Web of Science ®Google Scholar
• Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+ CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol.178(4), 2572–2578 (2007).
   PubMed Web of Science ®Google Scholar
• Kallikourdis M, Betz AG. Periodic accumulation of regulatory T cells in the uterus: preparation for the implantation of a semi-allogeneic fetus? PLoS ONE2, e382 (2007).
   PubMed Web of Science ®Google Scholar
• Kallikourdis M, Andersen KG, Welch KA, Betz AG. Alloantigen-enhanced accumulation of CCR5+ ‘effector’ regulatory T cells in the gravid uterus. Proc. Natl Acad. Sci. USA104(2), 594–599 (2007).
   PubMedGoogle Scholar
• Jasper MJ, Tremellen KP, Robertson SA. Reduced expression of IL-6 and IL-1α mRNAs in secretory phase endometrium of women with recurrent miscarriage. J. Reprod. Immunol.73(1), 74–84 (2007).
   PubMed Web of Science ®Google Scholar
• Robertson SA, Guerin LR, Bromfield JJ. Male seminal constituents activate expansion of the T regulatory cell pool in early pregnancy. Journal of Reproductive Immunology Banff conference on Reproductive Immunology, Banff, Canada 15–18 November, 2006.
   Google Scholar
• Delage G, Moreau J-F, Taupin J-L et al.In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. Hum. Reprod.10, 2483–2488 (1995).
   PubMed Web of Science ®Google Scholar
• Delage G, Moreau J-F, Taupin J-L et al. Abnormal endometrial reactivity to colony stimulating factor 1 and leukemia inhibitory factor dependent female infertility. Contracept. Fertil. Sex.25, 711–716 (1997).
   PubMedGoogle Scholar
• Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, LiI TC, Zhang X. The production of leukemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum. Reprod.12, 569–574 (1997).
   PubMedGoogle Scholar
• Giess R, Tanasescu I, Steck T, Sendtner M. Leukaemia inhibitory factor gene mutations in infertile women. Mol. Hum. Reprod.6, 581–586 (1999).
   Google Scholar
• Laird SM, Tuckerman EM, Li TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod. Biomed. Online13(1), 13–23 (2006).
   PubMed Web of Science ®Google Scholar
• Kralickova M, Sima R, Vanecek T et al. Leukemia inhibitory factor gene mutations in the population of infertile women are not restricted to nulligravid patients. Eur. J. Obstet. Gynecol. Reprod. Biol.127(2), 231–235 (2006).
   PubMedGoogle Scholar
• Zenclussen AC, Gerlof K, Zenclussen ML et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am. J. Pathol.166(3), 811–822 (2005).
   PubMed Web of Science ®Google Scholar
• Zenclussen AC. CD4+CD25+ T regulatory cells in murine pregnancy. J. Reprod. Immunol.65(2), 101–110 (2005).
   PubMed Web of Science ®Google Scholar
• Zenclussen AC, Gerlof K, Zenclussen ML et al. Regulatory T cells induce a privileged tolerant microenvironment at the fetal–maternal interface. Eur. J. Immunol.36(1), 82–94 (2006).
   PubMed Web of Science ®Google Scholar
• Zenclussen AC. Regulatory T cells in pregnancy. Springer Semin. Immunopathol.28(1), 31–39 (2006).
   PubMed Web of Science ®Google Scholar
• Schumacher A, Wollenberg I, Bertoja AZ et al. Pregnancy-protective regulatory T cells act in an antigen-specific manner. 4th European Congress of Reproductive Immunology, Graz, Austria, 5–9 July, 56(1), 1–78 (2006) (Abstract 0109).
   Google Scholar
• Schumacher A, Wafula PO, Teles A, Yagita H, Volk H-D, Zenclussen AC. IL-10 but not TGF-β is essential for the suppressor function of Treg cells in murine pregnancy. Am. J. Reprod. Immunol.57(6), 379–496 (2007).
   Google Scholar
• Fallon PG, Jolin HE, Smith P et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity17(1), 7–17 (2002).
   PubMed Web of Science ®Google Scholar
• White CA, Johansson M, Roberts CT, Ramsay AJ, Robertson SA. Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol. Reprod.70(1), 123–131 (2004).
   PubMed Web of Science ®Google Scholar
• Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J. Immunol.177(7), 4888–4896 (2006).
   PubMed Web of Science ®Google Scholar
• Clark DA, Manuel J, Lee L, Chaouat G, Gorczynski RM, Levy GA. Ecology of danger-dependent cytokine-boosted spontaneous abortion in the CBA × DBA/2 mouse model. I. Synergistic effect of LPS and (TNF-α + IFN-γ) on pregnancy loss. Am. J. Reprod. Immunol.52(6), 370–378 (2004).
   PubMed Web of Science ®Google Scholar
• Clark DA, Yu G, Arck PC, Levy GA, Gorczynski RM. MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome. Am. J. Reprod. Immunol.49(5), 297–307 (2003).
   PubMed Web of Science ®Google Scholar
• Clark DA, Coker R.Transforming growth factor-β (TGF-β). Int. J. Biochem. Cell Biol.30(3), 293–298 (1998).
   PubMed Web of Science ®Google Scholar
• Hamilton MS, Hamilton BL. Environmental influences on immunologically associated recurent spontaneous abortion in CBA/J mice. J. Reprod. Immunol.11, 237–241 (1987).
   PubMedGoogle Scholar
• Zenclussen AC, Blois S, Stumpo R et al. Murine abortion is associated with enhanced interleukin-6 levels at the feto–maternal interface. Cytokine24(4), 150–160 (2003).
   PubMedGoogle Scholar
• Chaouat G. Re: pregnancy-induced ‘tolerance’, and the involvement of T cells in this process. Eur. J. Immunol.36(8), 2273–2275 (2006).
   PubMedGoogle Scholar
• Heikkinen J, Mottonen M, Alanen A, Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin. Exp. Immunol.136(2), 373–378 (2004).
   PubMed Web of Science ®Google Scholar
• Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology118(1), 58–65 (2006).
   PubMed Web of Science ®Google Scholar
• Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res.84(2), 370–378 (2006).
   PubMed Web of Science ®Google Scholar
• Polanczyk MJ, Hopke C, Vandenbark AA, Offner H.Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int. Immunol.19(3), 337–343 (2007).
   PubMed Web of Science ®Google Scholar
• Shao L, Jacobs AR, Johnson VV, Mayer L. Activation of CD8+ regulatory T cells by human placental trophoblasts. J. Immunol.174(12), 7539–7547 (2005).
   PubMed Web of Science ®Google Scholar
• Joosten SA, van Meijgaarden KE, Savage ND et al. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl Acad. Sci. USA104(19), 8029–8034 (2007).
   PubMed Web of Science ®Google Scholar
• Tang X, Maricic I, Purohit N et al. Regulation of immunity by a novel population of Qa-1-restricted CD8αα+ TCRαβ+ T cells. J. Immunol.177(11), 7645–7655 (2006).
   PubMedGoogle Scholar
• Tang X, Maricic I, Kumar V. Anti-TCR antibody treatment activates a novel population of nonintestinal CD8αα+ TCR αβ+ regulatory T cells and prevents experimental autoimmune encephalomyelitis. J. Immunol.178(10), 6043–6050 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang ZX, Ma Y, Wang H et al. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas–Fas ligand-independent pathway. J. Immunol.177(10), 6920–6929 (2006).
   PubMedGoogle Scholar
• Thomson CW, Lee BP, Zhang L. Double-negative regulatory T cells: non-conventional regulators. Immunol. Res.35(1–2), 163–178 (2006).
   PubMedGoogle Scholar
• Ford MS, Chen W, Wong S et al. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development. Eur. J. Immunol.37(8), 2234–2241 (2007).
   PubMedGoogle Scholar
• Brooks-Kaiser JC, Murgita RA, Hoskin DW. Pregnancy-associated suppressor cells in mice: functional characteristics of CD3+4–8-45R+ T cells with natural suppressor activity. J. Reprod. Immunol.21(2), 103–125 (1992).
   PubMed Web of Science ®Google Scholar
• Offner H, Polanczyk M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann. NY Acad. Sci.1089, 343–372 (2006).
   PubMed Web of Science ®Google Scholar
• Huan J, Culbertson N, Spencer L et al. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res.81(1), 45–52 (2005).
   PubMed Web of Science ®Google Scholar